Journal profile · Biochemistry & Molecular Biology
EXPERIMENTAL AND MOLECULAR MEDICINE
ISSN 1226-3613 · eISSN 2092-6413 · Springer Nature · SOUTH KOREA · Quarterly · Founded 1999
EXPERIMENTAL AND MOLECULAR MEDICINE: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 17.53; fully open access; APC about USD 4,690; median 180 days to acceptance (97 articles, last 24 months); community-reported acceptance: about 65%; 235 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
EXPERIMENTAL AND MOLECULAR MEDICINE is published by Springer Nature and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are RNA modifications and cancer, Epigenetics and DNA Methylation and Cancer, Hypoxia, and Metabolism, together about 17.9% of its articles. Its main subfields are Molecular Biology and Cancer Research. (generated from OpenAlex topic counts and CAS ranking data)
Focuses on latest developments & discoveries in translational & biomedical research fields. Welcomes papers dealing with clear in vivo relevance and novelty, and basic discoveries. Open access publication ensures that your work is easily discovered, accessed and shared.
From the journal's Aims & Scope
Research area (LetPub): Biochemistry & Molecular Biology
Main research topics OpenAlex counts of recent articles; shares are approximate
- RNA modifications and cancerBiochemistry, Genetics and Molecular Biology6.7%
- Epigenetics and DNA MethylationBiochemistry, Genetics and Molecular Biology5.8%
- Cancer, Hypoxia, and MetabolismBiochemistry, Genetics and Molecular Biology5.4%
- Immune Cell Function and InteractionImmunology and Microbiology4.9%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology4.6%
- Pancreatic function and diabetesMedicine4.5%
- Cancer-related molecular mechanisms researchBiochemistry, Genetics and Molecular Biology4.5%
- Adipose Tissue and MetabolismMedicine4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Biochemistry & Molecular Biology | Zone 1 |
| Minor | Medicine, Research & Experimental | Zone 2 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Biochemistry & Molecular Biology | Zone 1 |
| Minor | Medicine, Research & Experimental | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Biochemistry & Molecular Biology | Zone 2 |
| Minor | Medicine, Research & Experimental | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEPubMedCASPublisher website
Other: Google Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 17.53LetPub ·
- Impact factor (publisher) 2025
- 17.5Publisher website ·
- 5-year impact factor (publisher) 2025
- 17.8Publisher website ·
- CiteScore 2026-06
- 22.6LetPub ·
- SJR 2026-06
- 5.12LetPub ·
- SNIP 2026-06
- 3.01LetPub ·
- h-index
- 68LetPub ·
- h-index
- 182OpenAlex ·
- i10-index
- 2,557OpenAlex ·
- 2-year mean citedness
- 14.89OpenAlex ·
- Self-citation rate
- 0.6%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 215LetPub ·
- Downloads per year (publisher) 2025
- 8,105,503Publisher website ·
Articles by year OpenAlex count · 3,827 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 229 | 229 | 326 |
| 2025 | 235 | 235 | 2,689 |
| 2024 | 239 | 239 | 7,454 |
| 2023 | 227 | 227 | 12,624 |
| 2022 | 193 | 193 | 11,468 |
| 2021 | 169 | 169 | 12,035 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
180 daysMedian, submission to acceptance · P25–P75 117 days – 231 days
- Acceptance to online
- median 83 days (97 articles)
- Submission to online
- median 267 days
- Sample
- 97 articles with submission and acceptance dates (527 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 3 monthsLetPub ·
- Average acceptance (community reports)
- 65%LetPub ·
- Submission to publication (journal-reported)
- about 5 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | EUR 3,990 / USD 4,690 / GBP 3,290 | Yes | CC BY | |
| OpenAlex | USD 4,490 / EUR 3,790 / GBP 3,190 | — | — | |
| LetPub | GBP 3,190 / USD 4,490 / EUR 3,790 | Yes | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websitePublication ethics
- Publication ethics
COPE member Model summary
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Nature
- Country or region
- SOUTH KOREA
- Language
- English
- Frequency
- Quarterly
- Founded
- 1999
- ISSN
- 1226-3613
- Electronic ISSN
- 2092-6413
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about EXPERIMENTAL AND MOLECULAR MEDICINE
What CAS zone is EXPERIMENTAL AND MOLECULAR MEDICINE in?
In the 2025 upgraded edition of the CAS Journal Ranking, EXPERIMENTAL AND MOLECULAR MEDICINE is in Zone 1 of Medicine, and in Zone 1 of the minor category Biochemistry & Molecular Biology / Medicine, Research & Experimental; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of EXPERIMENTAL AND MOLECULAR MEDICINE?
The latest impact factor listed by LetPub is 17.53; CiteScore 22.6, h-index 182.
How long does peer review take at EXPERIMENTAL AND MOLECULAR MEDICINE?
Based on the dates recorded on 97 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 180 days (interquartile range 117–231 days); authors report an average review time of about 3 months; the community-reported acceptance is “about 65%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index EXPERIMENTAL AND MOLECULAR MEDICINE?
According to LetPub and DOAJ records, EXPERIMENTAL AND MOLECULAR MEDICINE is indexed in SCIE, Scopus and DOAJ. The journal's website also lists MEDLINE, PubMed and CAS; that list has not been checked against each database.
Is EXPERIMENTAL AND MOLECULAR MEDICINE open access, and what is the APC?
EXPERIMENTAL AND MOLECULAR MEDICINE is a fully open-access journal. APC about USD 4,690.
Sources and updates
The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .